Patent Yard Sign in
Canadian application, no grantCanada

Fluoro labelled anthracyclinone and anthracycline derivatives for treatment and diagnosis of amyloidosis

CA 2258630 A1 · Owner: Lansen, Jacqueline · Inventors: Suarato, Antonino; Lansen, Jacqueline; Bandiera, Tiziano

CIPO record

Overview

Drawings and full text

Its claims, description and drawings are in the Canadian Patents Database.

Open the CIPO record

Abstract From the Canadian patent

Compounds of formula (A), wherein R1, R2 R3, Y and Z are organic , substituents are useful in the diagnosis of amyloidosis; some of the compounds of formula (A) are novel. Processes for their preparation and , pharmaceutical compositions containing them are also described.

Read the whole patent

Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.

Why it's free to use

  • Filed June 18, 1997. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended June 18, 2017.
  • A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by June 18, 2019.
  • We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
FiledJune 18, 1997
GrantedNo grant recorded
Term endedJune 18, 2017
Patent numberCA 2258630 A1
Classification (IPC)C07H15/25 +2 more

Timeline

Timeline From CIPO dates

1998200020022004200620082010201220142016Application filedJune 18, 1997Term endedJune 18, 2017

Sources & verification

Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.